Other ALS-associated mutants – SOD1, TDP-43, UBQLN2 and FUS – also specifically inhibit ER–Golgi transport in neuronal cells, providing evidence that this is a common pathophysiological mechanism amongst diverse forms of ALS and may provide an avenue for therapeutic development [28, 81]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.